Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.
2.

Validity of self-reported hypertension: findings from the Thai Cohort Study compared to physician telephone interview.

Thawornchaisit P, De Looze F, Reid CM, Seubsman SA, Sleigh A; Thai Cohort Study Team..

Glob J Health Sci. 2013 Nov 10;6(2):1-11. doi: 10.5539/gjhs.v6n2p1.

3.

Cost-effectiveness of secondary screening modalities for hypertension.

Wang YC, Koval AM, Nakamura M, Newman JD, Schwartz JE, Stone PW.

Blood Press Monit. 2013 Feb;18(1):1-7. doi: 10.1097/MBP.0b013e32835d0fd3. Review.

4.

Frequency and related factors of masked hypertension at a worksite in Korea.

Kim SK, Bae JH, Nah DY, Lee DW, Hwang TY, Lee KS.

J Prev Med Public Health. 2011 May;44(3):131-9. doi: 10.3961/jpmph.2011.44.3.131.

5.

Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures.

Shimbo D, Kuruvilla S, Haas D, Pickering TG, Schwartz JE, Gerin W.

J Hypertens. 2009 Sep;27(9):1775-83. doi: 10.1097/HJH.0b013e32832db8b9.

6.

Impact of white-coat hypertension on microvascular complications in type 2 diabetes.

Kramer CK, Leitão CB, Canani LH, Gross JL.

Diabetes Care. 2008 Dec;31(12):2233-7. doi: 10.2337/dc08-1299.

7.

Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?

Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G.

Br J Gen Pract. 2003 Oct;53(495):794-6.

9.

Prevalence and predictors of white-coat response in patients with treated hypertension.

MacDonald MB, Laing GP, Wilson MP, Wilson TW.

CMAJ. 1999 Aug 10;161(3):265-9.

10.
11.

Persistence with treatment for hypertension in actual practice.

Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD.

CMAJ. 1999 Jan 12;160(1):31-7.

Items per page

Supplemental Content

Support Center